IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	22.48	19.23	17.19	12.83	9.33
Depreciation & Amortization	1.17	0.82	0.77	0.67	1.41
Stock-Based Compensation	2.92	2.52	2.19	1.39	1.46
Other Adjustments	2.73	-0.7	-0.77	0.21	0.64
Change in Receivables	-3.03	1.76	0.84	-8.24	-0.58
Changes in Inventories	-1.38	3.13	-7.47	-1.31	-0.39
Changes in Accounts Payable	-0.08	-0.86	-0.22	1.12	0.03
Changes in Accrued Expenses	-0.55	1	-0.1	0.06	1.1
Changes in Income Taxes Payable	-0.76	-0.79	0.25	3.05	-0.83
Changes in Unearned Revenue	1.6	-0.11	0.62	0.53	0.05
Changes in Other Operating Activities	-0.15	-0.38	0.16	-0.27	-0.96
Operating Cash Flow	24.95	25.62	13.47	10.04	11.26
Operating Cash Flow Growth	-2.64%	90.30%	34.08%	-10.80%	93.52%
Capital Expenditures	-7.77	-8.01	-7.44	-0.82	-0.48
Purchases of Intangible Assets	-0.66	-0.81	-0.57	-1.05	-0.26
Proceeds from Sale of Investments	-	-	-	0.5	1.39
Investing Cash Flow	-8.42	-8.82	-8.01	-1.37	0.65
Issuance of Common Stock	-	0.03	0.18	0.15	0.62
Repurchase of Common Stock	-2.56	-0.69	-0.61	-0.29	-0.6
Net Common Stock Issued (Repurchased)	-2.56	-0.66	-0.43	-0.15	0.02
Common Dividends Paid	-15.04	-13.68	-13.22	-12.56	-
Financing Cash Flow	-17.6	-14.34	-13.66	-12.71	0.02
Net Cash Flow	-1.08	2.47	-8.2	-4.04	11.93
Free Cash Flow	17.18	17.62	6.02	9.22	10.78
Free Cash Flow Growth	-2.48%	192.46%	-34.66%	-14.44%	100.50%
FCF Margin	20.50%	24.06%	9.19%	17.30%	25.77%
Free Cash Flow Per Share	1.34	1.38	0.47	0.73	0.86
Levered Free Cash Flow	14.56	14.04	3.77	15.86	9.25
Unlevered Free Cash Flow	12.81	12.2	2.42	15.42	9.23

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q